Efficacy News and Research

RSS
Cymbalta approved for fibromyalgia

Cymbalta approved for fibromyalgia

Patch protects travellers from holiday diarrhoea

Patch protects travellers from holiday diarrhoea

Biological medicine helps more people with rheumatoid arthritis

Biological medicine helps more people with rheumatoid arthritis

Nanoparticles trigger built-in cell-death signal to overcome drug resistance

Nanoparticles trigger built-in cell-death signal to overcome drug resistance

Nanoparticle delivers antisense agent to tumors

Nanoparticle delivers antisense agent to tumors

Maxygen receives approval for trial of factor VIIa in UK

Maxygen receives approval for trial of factor VIIa in UK

Viruses genetically designed to kill cancer cells influence tumor blood-vessel growth

Viruses genetically designed to kill cancer cells influence tumor blood-vessel growth

European research project to explore Alzheimer's diagnosis

European research project to explore Alzheimer's diagnosis

Calls for tougher rules on complementary medicines in Australia

Calls for tougher rules on complementary medicines in Australia

Chinese red yeast rice reduces repeat heart attacks

Chinese red yeast rice reduces repeat heart attacks

FDA grants pediatric exclusivity for UCB's Keppra

FDA grants pediatric exclusivity for UCB's Keppra

New grant to enable University of Rochester to increase HIV research by 25 percent

New grant to enable University of Rochester to increase HIV research by 25 percent

Clostridium difficile killed on exposure to surfaces made of copper and its alloys, brass and bronze

Clostridium difficile killed on exposure to surfaces made of copper and its alloys, brass and bronze

Paclitaxel Poliglumex/Capecitabine regimen well tolerated and active in metastatic breast cancer

Paclitaxel Poliglumex/Capecitabine regimen well tolerated and active in metastatic breast cancer

Cetuximab and chemotherapy combination proves safe, effective for head and neck cancer patients

Cetuximab and chemotherapy combination proves safe, effective for head and neck cancer patients

New approach to treating vision loss caused by type 1 Usher syndrome

New approach to treating vision loss caused by type 1 Usher syndrome

Peregrine Pharmaceuticals updates on Bavituximab breast cancer study

Peregrine Pharmaceuticals updates on Bavituximab breast cancer study

University of Pennsylvania researcher to launch drug trial in Chinese province among IDUs

University of Pennsylvania researcher to launch drug trial in Chinese province among IDUs

Novel approach to drug insolubility strengthens PolyTherics patent estate

Novel approach to drug insolubility strengthens PolyTherics patent estate

An alternative strategy for HIV vaccine research

An alternative strategy for HIV vaccine research

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.